BioAdvance Commits $3.2M to Life Sciences Companies in First Six Months of FY 2018

BioAdvance announced today that it has added six new companies to its portfolio and has made follow-on investments in five of its existing companies, including two investments previously announced. These investments represent a commitment of $3.2M to the success and growth of life science companies in the mid-Atlantic region.

Brianna Wronko